If you made any changes in Pure these will be visible here soon.

Research Output 2001 2020

Filter
Review article
2020

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis

Schettini, F., Pascual, T., Conte, B., Chic, N., Brasó-Maristany, F., Galván, P., Martínez, O., Adamo, B., Vidal, M., Muñoz, M., Fernández-Martinez, A., Rognoni, C., Griguolo, G., Guarneri, V., Conte, P. F., Locci, M., Brase, J. C., Gonzalez-Farre, B., Villagrasa, P., De Placido, S. & 8 others, Schiff, R., Veeraraghavan, J., Rimawi, M. F., Osborne, C. K., Pernas, S., Perou, C. M., Carey, L. A. & Prat, A., Mar 2020, In : Cancer Treatment Reviews. 84, 101965.

Research output: Contribution to journalReview article

Meta-Analysis
Hormones
Breast Neoplasms
Odds Ratio
Drug Therapy
2019

Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status

Gadducci, A., Guarneri, V., Peccatori, F. A., Ronzino, G., Scandurra, G., Zamagni, C., Zola, P. & Salutari, V., Jan 28 2019, In : Journal of Ovarian Research. 12, 1, p. 1-8 9 p.

Research output: Contribution to journalReview article

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S. & 9 others, Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L. & Russo, A., Aug 1 2019, In : Critical Reviews in Oncology/Hematology. 140, p. 67-72 6 p.

Research output: Contribution to journalReview article

Open Access
Ovarian Neoplasms
BRCA1 Gene
Neoplasms
Primary Prevention
Secondary Prevention
2018

Olaparib for the treatment of breast cancer

Griguolo, G., Dieci, M. V., Guarneri, V. & Conte, P., Jun 2018, In : Expert Review of Anticancer Therapy. 18, 6, p. 519-530 12 p.

Research output: Contribution to journalReview article

Triple Negative Breast Neoplasms
Breast Neoplasms
BRCA2 Gene
BRCA1 Gene
Therapeutics
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
Oncogenes
Therapeutics
2017

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

Miglietta, F., Dieci, M. V., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 1 2017, In : Cancer Treatment Reviews. 60, p. 100-108 9 p.

Research output: Contribution to journalReview article

Breast Neoplasms
Drug Therapy
Standard of Care
Meta-Analysis
Decision Making

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

Meattini, I., Curigliano, G., Terziani, F., Becherini, C., Airoldi, M., Allegrini, G., Amoroso, D., Barni, S., Bengala, C., Guarneri, V., Marchetti, P., Martella, F., Piovano, P., Vannini, A., Desideri, I., Tarquini, R., Galanti, G., Barletta, G. & Livi, L., May 2017, In : Medical Oncology. 34, 5, p. 75

Research output: Contribution to journalReview article

Anthracyclines
Breast Neoplasms
Placebos
Bisoprolol
Ramipril